MDWD [NASD]
MediWound Ltd.
Index- P/E- EPS (ttm)-0.53 Insider Own32.26% Shs Outstand33.48M Perf Week-10.00%
Market Cap59.08M Forward P/E- EPS next Y-0.30 Insider Trans0.00% Shs Float27.60M Perf Month3.60%
Income-16.30M PEG- EPS next Q-0.10 Inst Own21.50% Short Float / Ratio0.34% / 0.69 Perf Quarter-22.99%
Sales20.40M P/S2.90 EPS this Y-45.90% Inst Trans180.18% Short Interest0.09M Perf Half Y-22.99%
Book/sh0.05 P/B28.80 EPS next Y37.50% ROA-68.10% Target Price7.10 Perf Year-40.00%
Cash/sh0.42 P/C3.40 EPS next 5Y- ROE- 52W Range1.21 - 3.38 Perf YTD-38.98%
Dividend- P/FCF- EPS past 5Y10.50% ROI432.60% 52W High-61.24% Beta1.10
Dividend %- Quick Ratio2.50 Sales past 5Y72.50% Gross Margin32.10% 52W Low8.26% ATR0.10
Employees77 Current Ratio2.70 Sales Q/Q-9.40% Oper. Margin-68.50% RSI (14)38.81 Volatility5.91% 7.46%
OptionableYes Debt/Eq0.00 EPS Q/Q-2.10% Profit Margin-80.00% Rel Volume4.01 Prev Close1.44
ShortableYes LT Debt/Eq0.59 EarningsNov 15 BMO Payout- Avg Volume137.05K Price1.31
Recom1.80 SMA20-12.76% SMA50-8.19% SMA200-26.44% Volume502,184 Change-9.03%
Jul-18-22Resumed Oppenheimer Outperform $7
Sep-23-20Initiated BTIG Research Buy $6
Nov-28-16Initiated Aegis Capital Buy $11
Aug-17-16Initiated Wells Fargo Outperform
Apr-16-14Initiated Oppenheimer Outperform $25
Dec-05-22 04:05PM
Nov-15-22 08:15AM
07:00AM
Nov-09-22 08:00AM
Nov-03-22 08:00AM
07:00AM Loading…
Oct-25-22 07:00AM
Oct-18-22 07:00AM
Oct-07-22 06:00AM
Sep-22-22 08:02AM
Sep-20-22 07:00AM
Sep-12-22 08:00AM
Aug-23-22 07:00AM
Aug-15-22 06:08AM
Aug-09-22 08:45AM
07:30AM
04:05PM Loading…
Aug-08-22 04:05PM
Aug-03-22 07:30AM
Aug-02-22 10:00AM
Aug-01-22 08:00AM
Jul-11-22 11:12AM
07:00AM
Jul-08-22 08:00AM
Jul-07-22 09:19AM
07:00AM
Jul-05-22 04:05PM
Jul-04-22 03:01PM
Jun-30-22 07:00AM
May-19-22 07:24AM
May-17-22 08:15AM
07:01AM
07:00AM Loading…
07:00AM
May-16-22 05:25PM
May-12-22 07:33AM
07:00AM
May-10-22 04:01PM
Apr-12-22 08:00AM
Mar-29-22 08:00AM
Mar-22-22 04:05PM
Mar-21-22 07:30AM
Mar-17-22 08:25AM
07:00AM
Mar-16-22 05:45PM
Mar-15-22 09:35AM
Mar-11-22 08:05AM
Mar-10-22 05:05PM
08:00AM
Mar-09-22 10:00AM
Mar-03-22 08:30AM
Mar-02-22 04:24PM
Mar-01-22 08:00AM
Feb-17-22 03:02PM
06:00AM
Feb-14-22 09:03AM
Feb-10-22 10:45AM
07:00AM
Jan-24-22 07:13AM
06:00AM
Jan-20-22 07:15AM
Dec-20-21 07:00AM
Dec-06-21 07:00AM
Nov-18-21 07:30AM
Nov-16-21 08:15AM
07:00AM
Nov-04-21 08:00AM
Nov-02-21 03:02PM
Oct-22-21 10:41AM
Oct-04-21 07:30AM
Sep-03-21 04:14PM
Aug-12-21 01:44AM
Aug-10-21 08:25AM
07:00AM
Aug-09-21 06:05AM
Aug-02-21 04:05PM
Jul-29-21 03:05PM
Jul-28-21 07:00AM
Jul-26-21 09:36AM
07:00AM
Jul-20-21 08:18AM
07:00AM
Jul-19-21 06:20AM
Jul-18-21 10:45AM
Jul-15-21 08:19PM
Jul-09-21 08:00AM
Jul-07-21 08:21PM
Jul-05-21 10:08PM
Jul-03-21 10:00PM
Jun-29-21 09:15PM
04:18PM
04:10PM
09:23AM
09:13AM
08:45AM
Jun-18-21 10:48AM
Jun-09-21 04:30PM
04:34AM
Jun-07-21 07:00AM
May-05-21 08:35AM
07:00AM
06:45AM
Apr-28-21 12:33PM
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.